Melt Extrusion: A Commercial Perception to Practicality
Over the past two decades, Meltrex® has evolved from being a novel processing technique into a comprehensive manufacturing technology. This chapter discusses the successful application of Meltrex® in the commercial development of delivery systems for varied drugs such as lopinavir (Kaletra®), ritonavir (Norvir®), ibuprofen, and verapamil hydrochloride (Isoptin®). Besides the commercial applications, Meltrex® can be successfully applied in design of solid dispersions (bioavailability enhancement of poorly soluble drugs), alter or control dissolution profiles (sustained release), reduced dosing frequency, deter substance abuse, improve safety, and efficacy of drugs. Moreover, continuous processing, rigorous and comprehensive regulatory documentation, and use of generally regarded as safe (GRAS) material are some of the striking features which make Meltrex® a popular drug delivery technology.
KeywordsSolid Dispersion Area Under Curve Tablet Formulation Amorphous Solid Dispersion Sustained Release Formulation
- AbbVie Deutschland GmbH & Co (2012) SOLIQS Global Drug Delivery Business, Germany. www.soliqs.com Accessed Nov 2012
- Bosch (2012) Technical literature on BOSCH hot melt extrusion lineWCF, BPK, BCK. Robert Bosch GmbH, Packaging Technology Division, Germany. www.boschconfectionery.com
- Breitenbach J, Lewis J (2008) Two concepts, one technology: controlled-release solid dispersions using melt extrusion (Meltrex®). In: Rathbone MJ, Roberts MS (eds) Modified-release drug delivery technology. Informa Healthcare, New York, pp 179–186Google Scholar
- Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281–1302. doi: 10.1002/jps.2600600902Google Scholar
- Shah S, Maddineni S et al (2012) Melt extrusion with poorly soluble drugs. Int J Pharm S0378–S5173(12):00990–00998Google Scholar